Your account is not claimed yet. You can sign up with ORCID to claim your account.

Olle Sangfelt

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 5

Top Venues

Oncogene

The EMBO journal

Cancer research

Molecular & cellular oncology

Karolinska Institutet

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet Aug 12o 2009

Sweden

Groupleader, Docent :: Department of Cell and Molecular Biology

Education History

Karolinska Institutet Aug 12o 1993 - Jun 8o 1998

Sweden

PHD :: Department of Oncology-Pathology

Publications

Anna Borgenvik, Karl O Holmberg, Sara Bolin, Miao Zhao, Vasil Savov, Gabriela Rosén, Sonja Hutter, Alexandra Garancher, Aldwin Suryo Rahmanto, Tobias Bergström, Thale Kristin Olsen, Oliver J Mainwaring, Damiana Sattanino, Annemieke D Verbaan, Jessica M Rusert, Anders Sundström, Mar Ballester Bravo, Yonglong Dang, Amelie S Wenz, Stacey Richardson, Grammatiki Fotaki, Rebecca M Hill, Adrian M Dubuc, Antonia Kalushkova, Marc Remke, Matko Čančer, Helena Jernberg-Wiklund, Géraldine Giraud, Xingqi Chen, Michael D Taylor, Olle Sangfelt, Steven C Clifford, Ulrich Schüller, Robert J Wechsler-Reya, Holger Weishaupt, Fredrik J Swartling
Dormant SOX9-positive cells facilitate MYC-driven recurrence of medulloblastoma. Cancer research (2022)
Belamy B Cheung, Ane Kleynhans, Rituparna Mittra, Patrick Y Kim, Jessica K Holien, Zsuzsanna Nagy, Olivia C Ciampa, Janith A Seneviratne, Chelsea Mayoh, Mukesh Raipuria, Satyanarayana Gadde, Hassina Massudi, Iris Poh Ling Wong, Owen Tan, Andrew Gong, Aldwin Suryano, Sonya M Diakiw, Bing Liu, Greg M Arndt, Tao Liu, Naresh Kumar, Olle Sangfelt, Shizhen Zhu, Murray D Norris, Michelle Haber, Daniel R Carter, Michael W Parker, Glenn M Marshall
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma. Oncogene 40 (13) (2021)
Andrä Brunner, Aldwin Suryo Rahmanto, Henrik Johansson, Marcela Franco, Johanna Viiliäinen, Mohiuddin Gazi, Oliver Frings, Erik Fredlund, Charles Spruck, Janne Lehtiö, Juha K Rantala, Lars-Gunnar Larsson, Olle Sangfelt
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer. eLife 9 (2020)
Aldwin Suryo Rahmanto, Fredrik J Swartling, Olle Sangfelt
Targeting SOX9 for degradation to inhibit chemoresistance, metastatic spread, and recurrence. Molecular & cellular oncology 4 (1) (2016)
Aldwin Suryo Rahmanto, Vasil Savov, Andrä Brunner, Sara Bolin, Holger Weishaupt, Alena Malyukova, Gabriela Rosén, Matko Čančer, Sonja Hutter, Anders Sundström, Daisuke Kawauchi, David Tw Jones, Charles Spruck, Michael D Taylor, Yoon-Jae Cho, Stefan M Pfister, Marcel Kool, Andrey Korshunov, Fredrik J Swartling, Olle Sangfelt
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma. The EMBO journal 35 (20) (2016)

Olle Sangfelt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Olle Sangfelt